Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma

Background & aims: Intrahepatic cholangiocarcinoma (iCCA) is the second most frequent primary liver tumor, characterized by clinical aggressiveness, dismal outcome, and limited therapeutic options. Thus, innovative treatments are urgently required to improve the prognosis of patients with iCCA....

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Wunan Mi, Antonio Cigliano, Grazia Galleri, Isabella Gigante, Sara Martina Steinmann, Ezgi Cibali, Marina Serra, Giovanni Mario Pes, Denise Schloesser, Elena Pizzuto, Heiko Siegmund, Claudia Fischer, Anna Saborowski, Gianluigi Giannelli, Matthias Evert, Luc Johannes Wilhelmus van der Laan, Monique Maria Andrea Verstegen, Diego Francesco Calvisi
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2025-07-01
Цуврал:	JHEP Reports
Нөхцлүүд:	Biliary tumors EIF4A1 Zotatifin Bcl-xl
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S258955592500093X
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!